Answers are grounded in this paper and cite their sources.
Background: Occult macular dystrophy (OMD) is a binocular hereditable macular disease caused by Retinitis pigmentosa 1-like 1(RP1L1) gene variation. Currently, there is no effective treatment for OMD. Low-level laser therapy (LLLT) is an innovative treatment for ophthalmological conditions by stimulate mitochondrial function. In this paper, we report a case of OMD and the effects of LLLT on this patient. Case Presentation: A 20-year-old man was diagnosed with OMD by genetic diagnosis. At presentation, the best corrected visual acuity (BCVA) was 3 letters (ETDRS) in his right eye (RE) and 12 letters in his left eye (LE). Spectral domain-optical coherence tomography (SD-OCT) revealed a blurred Elipsoid zone (EZ) and interdigitation zone (IZ) at the macular area of both eyes. The multifocal electroretinogram (MF-ERG) response amplitudes were reduced, and physiological blind spots were expanded in both eyes detected by perimetry. The full field electroretinogram (FF-ERG) examination, fluorescein angiograms (FFA), and fundus examination were normal. After an adequate evaluation of the safety of LLLT and with the patient's consent, the patient was treated with LLLT for 4 weeks (twice a day). For LLLT, the fundus was irradiated through the cornea for 180 sec with laser light (wavelength 650nm; average power 2.0±0.5 mW). The BCVA increased to 20 letters in both eyes, and the MF-ERG amplitude and vision sensitivity detected by the perimeter increased too. However, the morphology of the EZ and IZ measured by SD-OCT didn’t change. Conclusions: LLLT was shown to improve and maintain vision in a patient with OMD and may have contributed to improving the function of photoreceptor cells.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: